CXL treats radial keratotomy in the short-term

Article

Patients with radial keratotomy (RK) can be successfully treated with corneal cross-linking (CXL).

According to new results published in the journal Cornea patients with radial keratotomy (RK) can be successfully treated with corneal cross-linking (CXL).

The short-term case series, conducted by Dr Graciana Fuentes-Páez et al., Clinica Tacir-Centro Medico Teknon, Barcelona, Spain, featured seven eyes of four RK patients who underwent CXL with riboflavin and UV-A radiation.

Sphere, spherical equivalent (SE), uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), topographic astigmatism, mean topographic K (Km), pachymetry and Q values were all recorded 3 and 6 months after CXL.

After three months the findings revealed that the mean sphere of the patients was +1.0 ± 3.0 D, the astigmatism was 2.5 ± 1.2 D, SE was 0.3 ± 2.2 D and UCVA 0.41 ± 2.7. Additional findings showed that mean BSCVA was 0.80 ± 0.27, Km was 37.5 ± 5.7 D, pachymetry was 491 ± 33.74 μm and Q values were 2.27 ± 1.8.

Six months after CXL the findings improved further. Mean sphere was 0.53 ± 3.5 D, astigmatism was 1.62 ± 1.76 D, SE was 0.52 ± 2.9 D, UCVA was0.60 ± 2.0, BSCVA was 0.9 ± 0.15, Km was 38.3 ± 4.10 D, and Q values were 1.7 ± 0.78.

The data demonstrated a statistical and clinical significance in all areas on RK patients who underwent CXL.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.